SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COMMON STOCK
Total 13F shares
23,454,567
Share change
+11,994,721
Total reported value
$120,808,725
Put/Call ratio
743%
Price per share
$5.15
Number of holders
68
Value change
+$62,046,855
Number of buys
52
Number of sells
16

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q1 2018

As of 31 Mar 2018, SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,454,567 shares. The largest 10 holders included STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Intellectus Partners, LLC, Man Group plc, DEUTSCHE BANK AG\, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., and WELLS FARGO & COMPANY/MN. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.